| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.16 | 0.0008 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.076 | 0.08 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.091 | 0.08 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |